Article thumbnail

Neurotoxic Alkaloids: Saxitoxin and Its Analogs

By Maria Wiese, Paul M. D’Agostino, Troco K. Mihali, Michelle C. Moffitt and Brett A. Neilan


Saxitoxin (STX) and its 57 analogs are a broad group of natural neurotoxic alkaloids, commonly known as the paralytic shellfish toxins (PSTs). PSTs are the causative agents of paralytic shellfish poisoning (PSP) and are mostly associated with marine dinoflagellates (eukaryotes) and freshwater cyanobacteria (prokaryotes), which form extensive blooms around the world. PST producing dinoflagellates belong to the genera Alexandrium, Gymnodinium and Pyrodinium whilst production has been identified in several cyanobacterial genera including Anabaena, Cylindrospermopsis, Aphanizomenon Planktothrix and Lyngbya. STX and its analogs can be structurally classified into several classes such as non-sulfated, mono-sulfated, di-sulfated, decarbamoylated and the recently discovered hydrophobic analogs—each with varying levels of toxicity. Biotransformation of the PSTs into other PST analogs has been identified within marine invertebrates, humans and bacteria. An improved understanding of PST transformation into less toxic analogs and degradation, both chemically or enzymatically, will be important for the development of methods for the detoxification of contaminated water supplies and of shellfish destined for consumption. Some PSTs also have demonstrated pharmaceutical potential as a long-term anesthetic in the treatment of anal fissures and for chronic tension-type headache. The recent elucidation of the saxitoxin biosynthetic gene cluster in cyanobacteria and the identification of new PST analogs will present opportunities to further explore the pharmaceutical potential of these intriguing alkaloids

Topics: Review
Publisher: Molecular Diversity Preservation International
OAI identifier:
Provided by: PubMed Central

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

Suggested articles


  1. (1993). 3H-Saxitoxinol metabolism and elimination in the rat. Toxicon
  2. A compendium of the responses of bivalve molluscs to toxic dinoflagellates.
  3. (1998). A modified HPLC method for analysis of PSP toxins in algae and shellfish from china. Chromatographia
  4. (1995). A new saxitoxin analogue from a xanthid crab Atergatis floridus. Toxicon
  5. (1998). A re-examination of tetrodotoxin for prolonged duration local anesthesia. Anesthesiology
  6. (2009). A renaissance in marine pharmacology: From preclinical curiosity to clinical reality.
  7. (2006). a toxic marine natural product that targets a multitude of receptors.
  8. (2005). A.; Gó ngora-Gonzá lez, D.T. Comparative paralytic shellfish toxin profiles in the strains of Gymnodinium catenatum Graham from the Gulf of
  9. (2006). Accumulation and depuration profiles of PSP toxins in the short-necked clam Tapes japonica fed with the toxic dinoflagellate Alexandrium catenella. Toxicon
  10. (2004). Accumulation of paralytic shellfish toxins (PST) from the cyanobacterium Aphanizomenon issatschenkoi by the cladoceran Daphnia magna. Toxicon
  11. (2001). Accumulation, transformation and elimination of PSP in Mytilus edulis.
  12. (2009). Adopting alternatives for the regulatory monitoring of shellfish for paralytic shellfish poisoning in Canada: Interface between federal regulators, science and ethics.
  13. (2006). Analysis of paralytic shellfish toxins
  14. (1993). Anatomical distribution and spatio-temporal variation in paralytic shellfish toxin composition in two bivalve species from the Gulf of
  15. (2009). Atypical profiles of paralytic shellfish poisoning toxins in shellfish from Luanda and Mussulo bays, Angola. Toxicon
  16. (2008). Bacterial degradation of paralytic shellfish toxins. Toxicon
  17. (1985). Bacterial transformation of paralytic shellfish toxins in coral reef crabs and a marine snail. Nippon Suisan Gakk.
  18. (1995). Bioaccumulation of paralytic shellfish poisoning (PSP) toxins from the cyanobacterium Anabaena circinalis by the freshwater mussel Alathyria condola. Toxicon
  19. (2007). Biochemical characterization of paralytic shellfish toxin biosynthesis in
  20. (2010). Biosynthesis of the Lyngbya wollei (Farlow ex Gomont) paralytic shellfish toxins - natural biocombinatorics. PLoS One
  21. (2008). Biosynthetic intermediate analysis and functional homology reveal a saxitoxin gene cluster in cyanobacteria.
  22. (2001). Biotransformations of paralytic shellfish toxins by bacteria isolated from bivalve molluscs.
  23. (1998). Botulinum toxin injections in the internal anal sphincter for the treatment of chronic anal fissure: Long-term results after two different dosage regimens.
  24. (1997). Change of paralytic shellfish poison by the marine bacteria living in the intestine of the Japanese surf clam, Pseudocardium sybillae, and the brown sole, Pleuronectes herensteini.
  25. (2009). Characterisation of the paralytic shellfish toxin biosynthesis gene clusters
  26. (2008). Characterization of intracellular and extracellular saxitoxin levels in both field and cultured Alexandrium spp. samples from Sequim Bay,
  27. (1995). Chemical and enzymatic transformation of paralytic shellfish toxins in marine organisms. In Harmful Marine Algal Blooms; Lassus,
  28. (2000). Chemistry and mechanism of action. In Seafood and Freshwater Toxins: Pharmacology, Physiology, and Detection;
  29. (2008). Combinatorial biosynthesis of natural products.
  30. (2000). Comparative efficiencies of different non-toxic microalgal diets in detoxification of PSP-contaminated oysters (Crassoatrea gigas
  31. (2010). Comparative gene expression in toxic versus non-toxic strains of the marine dinoflagellate Alexandrium minutum.
  32. (2010). Comparative studies on paralytic shellfish toxin profile of dinoflagellates and bivalves.
  33. (1993). Comparative study on paralytic shellfish toxin profiles of the dinoflagellate Gymnodinium catenatum from three different countries.
  34. (2002). Comparison of changes in toxicity during growth of Anabaena circinalis (cyanobacteria) determined by mouse neuroblastoma bioassay
  35. (1997). Comparison of enzyme immunoassay and mouse bioassay for determining paralytic shellfish poisoning toxins in shellfish. Food Addit. Contam.
  36. (1982). Comparison of the toxins of the blue-green alga Aphanizomenon flos-aquae with the Gonyaulax toxins. Toxicon
  37. (2008). Complex profiles of hydrophobic paralytic shellfish poisoning compounds in Gymnodinium catenatum identified by liquid chromatography with fluorescence detection and mass spectrometry.
  38. (2009). Conotoxins: Natural product drug leads.
  39. (2008). Cyanobacterial poisoning in livestock, wild mammals and birds—an overview.
  40. (1995). Cyanobacterial toxins: occurrence, properties and biological significance. Water Sci.
  41. (2005). Cyanobacterial toxins: risk management for health protection.
  42. (1999). Cyanobacterial toxins. In Toxin Cyanobacteria in Water: A Guide to Their Public Health Consequences,
  43. (1995). Dinoflagellate Alexandrium tamarense as the source of paralytic shellfish poison (PSP) contained in bivalves from Hiroshima Bay,
  44. Drug development from marine natural products.
  45. (2003). Effects of exogenous polyamines on growth, toxicity, and toxin profile of dinoflagellate Alexandrium
  46. (1999). Effects of salinity, light and inorganic nitrogen on growth and toxigenicity of the marine dinoflagellate Alexandrium tamarense from northeastern
  47. (2002). Effects of toxic dinoflagellates and toxin biotransformation in bivalves.
  48. (1997). Environmental and nutritional factors which regulate population dynamics and toxin production in the dinoflagellate Alexandrium catenella. Hydrobiologia
  49. (1983). Enzymatic transformation of PSP toxins in the littleneck clam (Protothaca staminea).
  50. (2009). Evaluation of the production of paralytic shellfish poisoning toxins by extracellular bacteria isolated from the toxic dinoflagellate Alexandrium
  51. (2004). Evidence for differences in the metabolism of saxitoxin and
  52. (1997). Evidence for paralytic shellfish poisons in the freshwater cyanobacterium Lyngbya wollei (Farlow ex Gomont) comb.
  53. (1997). Evidence for production of paralytic shellfish toxins by bacteria associated with Alexandrium spp. (Dinophyta) in culture.
  54. (2009). Evidence of in vitro glucuronidation and enzymatic transformation of paralytic shellfish toxins by healthy human liver microsomes fraction. Toxicon
  55. (1994). Evolutionary relationships among pyridoxal-5'-phosphate-dependent enzymes.
  56. (2008). Fate of benzoate paralytic shellfish poisoning toxins from Gymnodinium catenatum in shellfish and fish detected by pre-column oxidation and liquid chromatography with fluorescence detection.
  57. (2010). First evidence of "paralytic shellfish toxins" and cylindrospermopsin in a Mexican freshwater system, Lago Catemaco, and apparent bioaccumulation of the toxins in "tegogolo" snails (Pomacea patula catemacensis). Toxicon
  58. (2006). First report of aphantoxins
  59. (2005). First report of saxitoxin in Finnish lakes and possible associated effects on human health.
  60. (1997). Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Res.
  61. (2000). Geographical patterns of occurrence and composition of saxitoxins in the cyanobacterial genus Anabaena (Nostocales, Cyanophyta) in Australia. Phycologia
  62. (2005). Gonyautoxin: New treatment for healing acute and chronic anal fissures. Dis. Colon Rectum
  63. (1994). Growth and toxin production of the toxic dinoflagellate Pyrodinium bahamense var. compressum in laboratory cultures.
  64. (2003). GTX4 imposters: Characterization of fluorescent compounds synthesized by Pseudomonas stutzeri SF/PS and Pseudomonas/Alteromonas PTB-1, symbionts of saxitoxin-producing Alexandrium spp. Toxicon
  65. (2002). Harmful algal blooms and eutrophication: Nutrient sources, composition, and consequences. Estuaries
  66. (2003). Harmful algal blooms: Causes, impacts and detection.
  67. (2004). High affinity for the rat brain sodium channel of newly discovered hydroxybenzoate saxitoxin analogues from the dinoflagellate Gymnodinium catenatum. Toxicon
  68. (1997). Hypertension and identification of toxin in human urine and serum following a cluster of musselassociated paralytic shellfish poisoning outbreaks. Toxicon
  69. (2008). Identification of a saxitoxin biosynthesis gene with a history of frequent horizontal gene transfers.
  70. (1960). In Enzymatic Basis of Detoxication; Jakob,
  71. (2006). In vitro transformation of paralytic shellfish toxins in the clams Mya arenaria and Protothaca staminea. Harmful Algae
  72. (2007). In vitro transformation of PSP toxins by different shellfish tissues. Harmful Algae
  73. (1991). Influence of dinoflagellate cell toxicity on uptake and loss of paralytic shellfish toxins in the northern quahog Mercenaria
  74. (2008). Investigating the fate of saxitoxins in biologically active water treatment plant filters.
  75. (1998). Investigation of the Streptomyces clavuligerus cephamycin C gene cluster and its regulation by the CcaR protein.
  76. (2008). Isolation and structure elucidation of new and unusual saxitoxin analogues from mussels.
  77. (1990). Lethal paralytic shellfish poisoning in Guatemala.
  78. (2009). Local infiltration of gonyautoxin is safe and effective in treatment of chronic tension-type headache.
  79. (2010). Magalhã es, V.F.; Wosiack, A.C.; Silva de Assis, H.C. Analyses of paralytic shellfish toxins and biomarkers in a southern Brazilian reservoir. Toxicon
  80. (2000). Marine algal toxins: Origins, health effects, and their increased occurrence. Environ. Health Perspect.
  81. Metabolic engineering for drug discovery and development.
  82. (2010). Metabolites of saxitoxin analogues in bivalves contaminated by Gymnodinium catenatum. Toxicon
  83. (1993). Microalgal metabolites.
  84. (2000). Molecular mechanisms of neurotoxin action on voltage-gated sodium channels. Biochimie
  85. (1989). Mycotoxins and Phycotoxins '88; Elsevier Applied Science:
  86. (2005). Natural guanidine derivatives.
  87. (1987). Neuronal calcium channel antagonists. Discrimination between calcium channel subtypes using omega-conotoxin from Conus magus venom. Biochemistry
  88. (1979). Neurotoxin binding to receptor sites associated with voltage-sensitive sodium channels in intact, lysed, and detergent-solubilized brain membranes.
  89. (1980). Neurotoxins that act on voltage-sensitive sodium channels in excitable membranes.
  90. (1997). New saxitoxin analogues from the freshwater filamentous cyanobacterium Lyngbya wollei.
  91. (2008). Non-traditional vectors for paralytic shellfish poisoning.
  92. (2004). Occurrence and elimination of cyanobacterial toxins in two Australian drinking water treatment plants. Toxicon
  93. (1998). Occurrence of a methyl derivative of saxitoxin in Bangladeshi freshwater puffers. Toxicon
  94. (2005). Occurrence of saxitoxins and an anatoxin-a(s)-like anticholinesterase in a Brazilian drinking water supply. Harmful Algae
  95. (2009). Origin of saxitoxin biosynthetic genes in cyanobacteria. PLoS ONE
  96. (1957). Paralytic shellfish poison VI. A procedure for the isolation and purification of the poison from toxic clams and mussel tissues.
  97. (1996). Paralytic shellfish poisoning in Southern China. Toxicon
  98. (2010). Paralytic shellfish poisoning toxin-producing cyanobacterium Aphanizomenon gracile in Northeast Germany.
  99. (2004). Paralytic shellfish poisoning: Post-mortem analysis of tissue and body fluid samples from human victims in the Patagonia fjords. Toxicon
  100. (1993). Paralytic shellfish poisoning. In Algal Toxins in Seafood and Drinking Water;
  101. (1986). Paralytic shellfish poisons produced by the freshwater cyanobacterium Aphanizomenon flos-aquae NH-5. Toxicon
  102. (2000). Paralytic shellfish toxins in Gymnodinium catenatum strains from six countries.
  103. (2000). Paralytic shellfish toxins in the freshwater cyanobacterium Aphanizomenon flos-aquae, isolated from Montargil reservoir, Portugal. Toxicon
  104. (1995). Phycotoxin-related shellfish poisoning: Bivalve molluscs are not the only vectors Rev.
  105. (2005). Phylogenetic analysis of toxic Alexandrium (Dinophyceae) isolates from South Africa: implications for the global phylogeography of the Alexandrium tamarense species complex. Phycologia
  106. (2002). Production of the paralytic shellfish toxins by Aphanizomenon sp.
  107. (2009). Prolonged duration local anesthesia with minimal toxicity.
  108. (2009). Pseudoalteromonas bacteria are capable of degrading paralytic shellfish toxins.
  109. (2001). PSP toxins from Aphanizomenon flos-aquae (cyanobacteria) collected in the Crestuma-Lever reservoir (Douro river, northern Portugal). Toxicon
  110. (2001). Purification and characterization of a sulfotransferase specific to N-21 of saxitoxin and gonyautosin 2+3 from the toxic dinoflagellate Gymnodinium catenatum (Dinophyceae)
  111. (2002). Purification and characterization of sulfotransferase specific to O-22 of 11-hydroxy saxitoxin from the toxic dinoflagellate Gymnodinium catenatum (dinophyceae).
  112. (2009). Quantification of saxitoxin and neosaxitoxin in human urine utilizing isotope dilution tandem mass spectrometry.
  113. (2001). Radioreceptor assays for sensitive detection and quantitation of saxitoxin and its analogues from strains of the freshwater cyanobacterium, Anabaena circinalis.
  114. (2007). S-adenosylmethionine synthetase genes from eleven marine dinoflagellates. Phycologia
  115. (2000). Saxitoxin and neosaxitoxin as toxic principles of Alexandrium andersoni (Dinophyceae) from the Gulf of Naples, Italy. Toxicon
  116. (2006). Saxitoxin puffer fish poisoning in the United States, with the first report of Pyrodinium bahamense as the putative toxin source. Environ. Health Perspect.
  117. (1989). Screening of bacteria which convert gonyautoxin 2,3 to saxitoxin. Nippon Suisan Gakk.
  118. (1989). Sequelae of internal sphincterotomy for chronic fissure in
  119. (2002). Singapore isolates of the dinoflagellate Gymnodinium catenatum (Dinophyceae) produce a unique profile of paralytic shellfish poisoning toxins.
  120. (2004). Site 1 sodium channel blockers prolong the duration of sciatic nerve blockade from tricyclic antidepressants. Pain
  121. (2009). Site-specific analgesia with sustained release liposomes.
  122. (1981). Specific toxicity of paralytic shellfish poisons.
  123. (1975). Structure of a crystalline derivative of saxitoxin.
  124. (1984). Surgical treatment of chronic anal fissure. Dis. Colon Rectum
  125. (2007). T.A.; Ruiz Sebastiá n, C. The dinoflagellate Alexandrium minutum in Cape Town harbour (South Africa): Bloom characteristics, phylogenetic analysis and toxin composition. Harmful Algae
  126. (2004). Taxonomy and production of paralytic shellfish toxins by the freshwater cyanobacterium Aphanizomenon gracile LMECYA40.
  127. (2006). Temperature as a factor regulating growth and toxin content in the dinoflagellate Alexandrium catenella. Harmful Algae
  128. (2006). The biosynthesis, molecular genetics and enzymology of the polyketide-derived metabolites.
  129. (2000). The diversity of harmful algal blooms: A challenge for science and management. Ocean Coast.
  130. (2004). The effect of temperature on growth and production of paralytic shellfish poisoning toxins by the cyanobacterium Cylindrospermopsis raciborskii C10. Toxicon
  131. (1999). The first evidence of paralytic shellfish toxins in the freshwater cyanobacterium Cylindrospermopsis raciborskii, isolated from Brazil. Toxicon
  132. (2000). The freshwater cyanobacterium Planktothrix sp. FP1: Molecular identification and detection of paralytic shellfish poisoning toxins.
  133. (2004). The gonyautoxin 2/3 epimers reduces anal tone when injected in the anal sphincter of healthy adults.
  134. (1976). The local anesthetic activity of saxitoxin alone and with vasoconstrictor and local anesthetic agents.
  135. (2000). The local anesthetic properties and toxicity of saxitonin homologues for rat sciatic nerve block in
  136. (1992). The marine dinoflagellate Alexandrium ostenfeldii: Paralytic shellfish toxin concentration, composition and toxicity to a tintinnid cilliate.
  137. (1975). The receptor for tetrodotoxin and saxitoxin. A structural hypothesis.
  138. (2004). The structure of zetekitoxin AB, a saxitoxin analog from the Panamanian golden frog Atelopus zeteki: A potent sodium-channel blocker.
  139. (1951). The surgical correction of chronic internal anal (sphincteric)
  140. (2003). Three novel hydroxybenzoate saxitoxin analogues isolated from the dinoflagellate Gymnodinium catenatum.
  141. (2003). Topical nifedipine vs. topical glyceryl trinitrate for treatment of chronic anal fissure. Dis. Colon Rectum
  142. (1995). Topical nitroglycerin therapy for anal fissures and ulcers.
  143. (1999). Toxic effects, pharmacokinetics and clearance of saxitoxin, a component of paralytic shellfish poison (PSP), in cats. Toxicon
  144. (1990). Toxin composition variations in one isolate of the dinoflagellate Alexandrium fundyense. Toxicon
  145. (2007). Toxin profile of Alexandrium catenella from the Chilean coast as determined by liquid chromatography with fluorescence detection and liquid chromatography coupled with tandem mass spectrometry. Harmful Algae
  146. (1994). Toxin profiles of natural populations and cultures of Alexandrium minutum Halim from Galician (Spain) coastal waters.
  147. (2005). Toxin variability in natural populations of Alexandrium fundyense in Casco Bay, Maine—evidence of nitrogen limitation. Deep-Sea Res.
  148. (2002). Toxins in the freshwater cyanobacterium Cylindrospermopsis raciborskii (Cyanophyceae) isolated from Tabocas reservoir in Caruaru, Brazil, including demonstration of a new saxitoxin analogue. Phycologia
  149. (1976). Toxins of the Gonyaulax sp. and infested bivalves in Owase
  150. (1981). Transformation of paralytic shellfish toxins as demonstrated in scallop homogenates. Science
  151. (2007). Treatment of chronic anal fissure by gonyautoxin. Colorectal Dis.
  152. (1990). Uptake kinetics of paralytic shellfish toxins from the dinoflagellate Alexandrium fundyense in the mussel Mytilus edulis.
  153. (1995). Urinary elimination of saxitoxin after intravenous injection. Toxicon
  154. (2002). Variety of PSP toxin profiles in various culture strains of Alexandrium tamarense and change of toxin profile in natural A. tamarense population.
  155. (1994). Widespread occurrence of three sequence motifs in diverse S-adenosylmethionine-dependent methyltransferases suggests a common structure for these enzymes.
  156. (2007). Widespread presence of hydrophobic paralytic shellfish toxins in Gymnodinium catenatum. Harmful Algae
  157. (2006). Ziconotide—a novel neuron-specific calcium channel blocker for the intrathecal treatment of severe chronic pain—a short review.